China's market regulator granted Chongqing Pharscin Pharmaceutical (SHE:002907) registration approval for its liquid formula food for individuals with restricted food intake, according to a Thursday filing with the Shenzhen bourse.
The formula is indicated for individuals aged 10 and above with restricted fat intake or those experiencing digestive and absorption disorders, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments